Preliminary Results of a Phase 2a Dose Optimization Study of ASLAN003 (DHODH inhibitor) in Acute Myeloid Leukemia (AML) Patients Who Are Ineligible for Standard Therapy; Early Signs of Activity
| Autor: | Ting, Stephen B *, Ng, Chin Hin *, Bajel, Ashish *, Hwang, William YK *, Ho, Shir-Jing *, Chng, Wee-Joo, McHale, Mark *, Hsieh, Chih-Yi *, Shih, Hsuan-Jen *, McIntyre, Nicola *, Kwek, Jamie *, Chang, Wei-Ling *, Lindmark, Bertil * |
|---|---|
| Zdroj: | In Blood 29 November 2018 132 Supplement 1:2676-2676 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|